SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Lerner Ulf)
 

Sökning: WFRF:(Lerner Ulf) > (2010-2014) > Nuclear androgen re...

Nuclear androgen receptor staining in bone metastases is related to a poor outcome in prostate cancer patients

Crnalic, Sead (författare)
Umeå universitet,Ortopedi
Hörnberg, Emma (författare)
Umeå universitet,Patologi
Wikström, Pernilla (författare)
Umeå universitet,Patologi
visa fler...
Lerner, Ulf H (författare)
Gothenburg University,Göteborgs universitet,Umeå universitet,Institutionen för odontologi,Institutionen för medicin, avdelningen för invärtesmedicin,Centre for Bone and Arthritis Research,Institute of Medicine, Department of Internal Medicine
Tieva, Åse (författare)
Umeå universitet,Onkologi
Svensson, Olle (författare)
Umeå universitet,Ortopedi
Widmark, Anders (författare)
Umeå universitet,Onkologi
Bergh, Anders (författare)
Umeå universitet,Patologi
visa färre...
 (creator_code:org_t)
2010
2010
Engelska.
Ingår i: Endocrine-Related Cancer. - 1351-0088 .- 1479-6821. ; 17:4, s. 885-895
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Androgen receptors (ARs) are probably of importance during all phases of prostate cancer (PC) growth, but their role in bone metastases is largely unexplored. Bone metastases were therefore collected from hormone-naive (n=11), short-term castrated (n=7) and castration-resistant PC (CRPC, n=44) patients by biopsy (n=4) or at surgery to alleviate symptoms from metastases complications (metastasis surgery, n=58), and immunostained for nuclear ARs, Ki67, active caspase-3, prostate-specific antigen (PSA) and chromogranin A, and results were related to serum PSA, treatments and outcome. Nuclear AR immunostaining was decreased and apoptosis was increased, but cell proliferation remained largely unaffected in metastases within a few days after surgical castration. In CRPC patients, nuclear AR staining of metastases was increased when compared to short-term castrated patients. The nuclear AR staining score was related to tumour cell proliferation, but it was not associated with other downstream effects of AR activation such as apoptosis and PSA staining, and it was only marginally related to the presence of neuroendocrine tumour cells. Serum PSA at metastasis surgery, although related to outcome, was not associated with AR staining, markers of metastasis growth or PSA staining in metastases. High nuclear AR immunostaining was associated with a particularly poor prognosis after metastasis surgery in CRPC patients, suggesting that such men may benefit from the potent AR blockers now tested in clinical trials.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Nyckelord

Oncology
Onkologi
Oncology
onkologi

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy